TABLE 5.
Cysteine and other amino acid associated extreme pathways.
| Pathway | Reaction |
| P16a | Cysteinyl–glycine + H2O → Cys + Gly |
| P68b | 4-Methylthio–2-oxobutanoate + Cys → Mercaptopyruvate + L-Methionine |
| P69c | Cysteate + 3H + + Mercaptopyruvate + 3NADPH → Cys + 2H2O + 3NADP + + Pyr + Sulfide |
| P70d | 7ATP + 2Ala + Asp + Cys + GlcN6P + Glu + H + + NAD + + 2NADPH + 2Pyr + UDP–MurNAc + Undecaprenol → 2P + 7ADP + CO2 + H2O + Mercaptopyruvate + NADH + 2NADP + + 6Orthophosphate + Peptidoglycan |
| P75e | 2ADP + 2Asp + GTP + ITP + 2Mercaptopyruvate → 2ATP + 2CO2 + 2Cys + GDP + IDP + 2Pyr |
| P81f | 2P + 3ADP + 3Cys + 2G6P + 12GTP + 3H + + 3NADPH + 6Pyr → 3ATP + 3CO2 + 12GDP + 3H2O + 3Mercaptopyruvate + 3NADP + + 13Orthophosphate + 3Phe |
Reactions involved based on KEGG reaction number: aR00899; bR07396, R00895; cR00858, R02433, R00895, R04861; dR00014, R03270, R02569, R07618, R00416, R05332, R02060, R03193, R02783, R02788, R01150, R04617, R05630, R05032, R00480, R02291, R10147, R04199, R07613, R02735, R00895, R05626; eR00431, R00200, R00895, R00355; fR01056, R01529, R02740, R01070, R01830, R01827, R01641, R01015, R02073, R00330, R01826, R03083, R03084, R02413, R02412, R03460, R01714, R00694, R00895, R01715, R01373.